Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Choroidal Morphology Changes After Aflibercept in Pachychoroid Neovasculopathy
NCT05662410Phase 4Completed
- Sponsor
- Kim's Eye Hospital
- Start
- Dec 2022
- Primary completion
- May 2024
- Modality
- Engineered Antibody Formats, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of aflibercept in pachychoroid neovasculopathy (PNV), sponsored by Kim's Eye Hospital. Started Dec 2022; status: completed.
02
Drugs
aflibercept
03
Conditions
pachychoroid neovasculopathy (PNV)
Beyond the preview
Go deeper on NCT05662410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05662410.